CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM...
Phase 3
San Antonio, Texas, United States and 85 other locations
This is a Phase 1 dose-escalation study of PRT3645, a Cyclin-dependent Kinase 4/6 (CDK4/6) inhibitor, in patients with advanced or metastatic solid t...
Phase 1
San Antonio, Texas, United States and 12 other locations
and tolerability of these combinations in adult participants with glioblastoma (GBM).The primary purpose of Phase 2 of this study is...
Phase 1, Phase 2
San Antonio, Texas, United States and 9 other locations
This research study is studying a new viral cancer therapy, ofranergene obadenovec (VB-111), for recurrent or progressive glioblastoma (GBM...
Phase 2
San Antonio, Texas, United States and 3 other locations
To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...
San Antonio, Texas, United States and 132 other locations
This is a multi-center, sequential cohort, open-label, volume and dose escalation study of the safety, tolerability, and distribution of 186RNL given...
Phase 1, Phase 2
San Antonio, Texas, United States and 2 other locations
followed by craniotomy with surgery or biopsy of brain tumors (GBM and metastatic brain tumors from Breast) and intraoperative tissue collec...
Early Phase 1
San Antonio, Texas, United States
Clinical trials
Research sites
Resources
Legal